ABL Bio Inc (298380) — Net Asset Momentum

Latest YoY growth as of December 2025: -6.3%

ABL Bio Inc (298380) recorded a net asset momentum of -6.3% as of December 2025, with net assets of ₩156.70 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ABL Bio Inc book value and equity for net asset value and shareholders' equity analysis.

YoY Momentum

-6.3%
Year-over-year

Current Net Assets

₩156.70 Billion
KRW · December 2025

Years of Data

10
2016 – 2025

Country

Korea
KQ

ABL Bio Inc Net Asset Momentum (2016–2025)

This chart tracks ABL Bio Inc's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is -6.3%, with net assets of ₩156.70 Billion KRW as of December 2025. For live market cap and overall valuation, see 298380 company net worth.

Annual Net Asset History for ABL Bio Inc (2016–2025)

The table below shows the complete annual net asset history for ABL Bio Inc from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check ABL Bio Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Year Net Assets (KRW) Total Assets Total Liabilities YoY Momentum
2025 ₩156.70 Billion ₩280.93 Billion ₩124.24 Billion ▼ -6.3%
2024 ₩167.28 Billion ₩231.98 Billion ₩64.70 Billion ▲ +125.8%
2023 ₩74.08 Billion ₩160.14 Billion ₩86.07 Billion ▲ +6.6%
2022 ₩69.51 Billion ₩185.18 Billion ₩115.67 Billion ▲ +24.2%
2021 ₩55.95 Billion ₩65.45 Billion ₩9.50 Billion ▼ -38.3%
2020 ₩90.66 Billion ₩99.89 Billion ₩9.23 Billion ▼ -31.3%
2019 ₩132.01 Billion ₩142.90 Billion ₩10.89 Billion ▼ -15.9%
2018 ₩156.96 Billion ₩168.87 Billion ₩11.91 Billion ▲ +282.6%
2017 ₩-85.96 Billion ₩20.37 Billion ₩106.32 Billion ▼ -610.4%
2016 ₩-12.10 Billion ₩7.53 Billion ₩19.63 Billion —